DBV Technologies Announces Creation Of US Subsidiary And Appoints Ms. Susanna Mesa As Vice President Of Finance, U.S. Investor Relations & Strategy

BAGNEUX, France, April 7, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new paradigm for the treatment of allergies, today announced that it has established a US subsidiary, DBV Technologies Inc., in order to conduct operations in the United States, and that it appointed Ms. Susanna Mesa as Vice President of Finance, US Investor Relations & Strategy.

Help employers find you! Check out all the jobs and post your resume.